Recombinant PCSK9 (Evolocumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-PCSK9 (Evolocumab Biosimilar) antibody (ABIN7488007) specifically detects PCSK9 (Evolocumab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7488007
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant PCSK9 (Evolocumab Biosimilar) antibody (ABIN7488007)
Target
PCSK9 (Evolocumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This PCSK9 (Evolocumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Evolocumab Biosimilar - Anti-PCSK9 mAb
-
Characteristics
- Antibody Type: IgG2-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG2 lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PCSK9 (Evolocumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
AMG 145,Anti-PCSK9
Evolocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia. -
CAS-No
- 1256937-27-5
Target
-
You are here:
